These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Postnatal and prenatal diagnosis of mucopolysaccharidosis type II (Hunter syndrome)]. Zhang WM, Shi HP, Li BT, Zhao SM, Qi QW, Sun NH, Huang SZ. Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):644-7. PubMed ID: 17217652 [Abstract] [Full Text] [Related]
7. Direct assay of iduronate-2-sulfatase for Hunter disease using UPLC-tandem mass spectrometry and fluorogenic substrate. Lee K, Jun SH, Song SH, Park HD, Park KU, Song J. Clin Biochem; 2015 Dec; 48(18):1350-3. PubMed ID: 26297117 [Abstract] [Full Text] [Related]
14. Case report: a rare case of Hunter syndrome (type II mucopolysaccharidosis) in a girl. Semyachkina AN, Voskoboeva EY, Zakharova EY, Nikolaeva EA, Kanivets IV, Kolotii AD, Baydakova GV, Kharabadze MN, Kuramagomedova RG, Melnikova NV. BMC Med Genet; 2019 May 02; 20(1):66. PubMed ID: 31046699 [Abstract] [Full Text] [Related]
16. Iduronate sulfatase determination for the diagnosis of the Hunter syndrome and the detection of the carrier state. Neufeld EF, Liebaers I, Lim TW. Adv Exp Med Biol; 1976 May 02; 68():253-60. PubMed ID: 820168 [No Abstract] [Full Text] [Related]
17. Identification of 9 novel IDS gene mutations in 19 unrelated Hunter syndrome (mucopolysaccharidosis Type II) patients. Mutations in brief no. 202. Online. Karsten SL, Voskoboeva E, Carlberg BM, Kleijer WJ, Tsnnesen T, Pettersson U, Bondeson ML. Hum Mutat; 1998 May 02; 12(6):433. PubMed ID: 10671065 [Abstract] [Full Text] [Related]